Novacyt Correlations
ALNOV Stock | EUR 0.54 0.04 6.90% |
The current 90-days correlation between Novacyt and Eurobio Scientific SA is 0.17 (i.e., Average diversification). The correlation of Novacyt is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Novacyt Correlation With Market
Good diversification
The correlation between Novacyt and DJI is -0.15 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Novacyt and DJI in the same portfolio, assuming nothing else is changed.
Novacyt |
The ability to find closely correlated positions to Novacyt could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Novacyt when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Novacyt - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Novacyt to buy it.
Moving together with Novacyt Stock
Moving against Novacyt Stock
0.62 | ENX | Euronext NV | PairCorr |
0.61 | ABCA | ABC arbitrage SA Earnings Call This Week | PairCorr |
0.6 | ALGIR | Signaux Girod | PairCorr |
0.6 | ML | Compagnie Generale des | PairCorr |
0.59 | BALYO | Balyo SA | PairCorr |
0.59 | CRI | Chargeurs SA | PairCorr |
0.57 | BEN | Bnteau SA | PairCorr |
0.56 | ALMET | Methanor | PairCorr |
0.56 | CARM | Carmila SA | PairCorr |
0.56 | VLA | Valneva SE | PairCorr |
0.55 | HO | Thales SA | PairCorr |
0.54 | ATO | Atos SE | PairCorr |
0.53 | EXA | Exail Technologies Earnings Call This Week | PairCorr |
0.52 | HDF | Hydrogene De France | PairCorr |
0.52 | IVA | Inventiva SA Earnings Call This Week | PairCorr |
0.51 | ALESK | Esker SA Earnings Call This Week | PairCorr |
0.49 | ALBPK | Broadpeak SA | PairCorr |
0.4 | CBDG | Compagnie du Cambodge | PairCorr |
0.4 | ALMOU | Moulinvest | PairCorr |
0.36 | LEBL | Foncire 7 investissement | PairCorr |
0.35 | ENGI | Engie SA | PairCorr |
0.64 | ALSMA | SMAIO SA | PairCorr |
0.63 | CRLO | Caisse Regionale | PairCorr |
0.62 | EXPL | EPC Groupe | PairCorr |
0.61 | ALTPC | Societe Marseillaise | PairCorr |
0.6 | CS | AXA SA | PairCorr |
0.55 | NRO | Neurones | PairCorr |
0.54 | SAN | Sanofi SA | PairCorr |
0.51 | ALDBT | DBT SA | PairCorr |
0.5 | ALLOG | Logic Instrume | PairCorr |
0.5 | AIR | Airbus Group SE | PairCorr |
0.5 | NOKIA | Nokia Oyj | PairCorr |
0.48 | ALPRO | Prodware | PairCorr |
0.47 | EXENS | EXOSENS PROM | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Novacyt Stock performing well and Novacyt Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Novacyt's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
ALBIO | 6.11 | 0.32 | 0.08 | (0.28) | 6.69 | 17.36 | 47.91 | |||
ALBPS | 3.03 | (0.03) | 0.02 | (0.07) | 5.43 | 6.90 | 46.49 | |||
ALERS | 0.49 | (0.05) | 0.00 | 0.18 | 0.00 | 0.59 | 8.80 | |||
ALINS | 2.07 | (0.11) | 0.00 | 0.27 | 0.00 | 4.17 | 14.81 |
Be your own money manager
Our tools can tell you how much better you can do entering a position in Novacyt without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Options Analysis Now
Options AnalysisAnalyze and evaluate options and option chains as a potential hedge for your portfolios |
All Next | Launch Module |
Novacyt Corporate Management
Elected by the shareholders, the Novacyt's board of directors comprises two types of representatives: Novacyt inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Novacyt. The board's role is to monitor Novacyt's management team and ensure that shareholders' interests are well served. Novacyt's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Novacyt's outside directors are responsible for providing unbiased perspectives on the board's policies.
Steve Gibson | Member of the Executive Team, Group Financial Controller | Profile | |
David Franks | Chief Officer | Profile | |
Grald Ulrich | Chief Devel | Profile | |
James McCarthy | Acting CFO | Profile | |
Wendy Karban | Member of the Executive Team, Group Human Resource Manager | Profile | |
Bryan Close | Chief Officer | Profile | |
Paul Oladimeji | Group RD | Profile |